Trial of Prasinezumab in Early-Stage Parkinson's Disease
Hoffmann-La Roche
Gennaro Pagano; Kirsten I Taylor; Judith Anzures-Cabrera; Maddalena Marchesi; Tanya Simuni; Kenneth Marek; Ronald B Postuma; Nicola Pavese; Fabrizio Stocchi; Jean-Philippe Azulay; Brit Mollenhauer; Lydia López-Manzanares; David S Russell; James T Boyd; Anthony P Nicholas; María R Luquin; Robert A Hauser; Thomas Gasser; Werner Poewe; Benedicte Ricci; Anne Boulay; Annamarie Vogt; Frank G Boess; Juergen Dukart; Giulia D'Urso; Rebecca Finch; Stefano Zanigni; Annabelle Monnet; Nathalie Pross; Andrea Hahn; Hanno Svoboda; Markus Britschgi; Florian Lipsmeier; Ekaterina Volkova-Volkmar; Michael Lindemann; Sebastian Dziadek; Štefan Holiga; Daria Rukina; Thomas Kustermann; Geoffrey A Kerchner; Paulo Fontoura; Daniel Umbricht; Rachelle Doody; Tania Nikolcheva; Azad Bonni; PASADENA Investigators; Prasinezumab Study Group